Literature DB >> 12024113

The renin-angiotensin system in experimental radiation nephropathy.

Eric P Cohen1, Brian L Fish, John E Moulder.   

Abstract

Irradiation of the kidneys is followed by a well-defined sequence of changes leading eventually to kidney failure. In the rat, inhibition of angiotensin-converting enzyme or blockade of angiotensin II receptors can prevent the structural and functional changes that occur after kidney irradiation. These interventions are particularly effective between 3 and 10 weeks after irradiation. However, in a series of studies with the rat model we failed to find any evidence that the renin-angiotensin system (RAS) is activated in the first 10 weeks after kidney irradiation. First, if the RAS was activated during this interval, one would expect hypertension followed by proteinuria and azotemia. However, hypertension is significant only at the end of this period and is preceded by significant proteinuria and azotemia. This evolution is not in favor of an obviously activated RAS during the 3- to 10-week postirradiation interval that is critical for interventions aimed at the RAS. Second, plasma renin activity and active plasma renin protein concentrations are not significantly increased over the first 10 weeks after irradiation. Third, whole-blood and intrarenal angiotensin II levels are not increased and may even be decreased over this interval. This last observation is particularly important because the assay used is sensitive enough to detect the effects of dietary salt manipulation. We hypothesize that even the normal activity of the RAS contributes to injury after kidney irradiation, possibly by supporting the proliferation of cells that carry potentially lethal radiation injuries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12024113     DOI: 10.1067/mlc.2002.122279

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  18 in total

1.  Chronic oxidative stress as a mechanism for radiation nephropathy.

Authors:  Marek Lenarczyk; Eric P Cohen; Brian L Fish; Amy A Irving; Mukut Sharma; Collin D Driscoll; John E Moulder
Journal:  Radiat Res       Date:  2009-02       Impact factor: 2.841

2.  Radiation nephropathy is not mitigated by antagonists of oxidative stress.

Authors:  Eric P Cohen; Brian L Fish; Amy A Irving; Mohan M Rajapurkar; Sudhir V Shah; John E Moulder
Journal:  Radiat Res       Date:  2009-08       Impact factor: 2.841

3.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

4.  Dietary selenium for the mitigation of radiation injury: effects of selenium dose escalation and timing of supplementation.

Authors:  Fritz Sieber; Sarah A Muir; Eric P Cohen; Brian L Fish; Marylou Mäder; Ashley M Schock; Bryan J Althouse; John E Moulder
Journal:  Radiat Res       Date:  2011-07-08       Impact factor: 2.841

5.  Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation.

Authors:  John E Moulder; Eric P Cohen; Brian L Fish
Journal:  Radiat Res       Date:  2010-10-26       Impact factor: 2.841

Review 6.  Chronic oxidative stress after irradiation: An unproven hypothesis.

Authors:  Samuel R Cohen; Eric P Cohen
Journal:  Med Hypotheses       Date:  2012-12-14       Impact factor: 1.538

7.  Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.

Authors:  John E Moulder; Eric P Cohen; Brian L Fish
Journal:  Int J Radiat Biol       Date:  2014-09       Impact factor: 2.694

8.  The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment.

Authors:  Mike E Robbins; Valerie Payne; Ellen Tommasi; Debra I Diz; Fang-Chi Hsu; William R Brown; Kenneth T Wheeler; John Olson; Weiling Zhao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-10       Impact factor: 7.038

9.  Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.

Authors:  Md Abdul Hye Khan; Brian Fish; Geneva Wahl; Amit Sharma; John R Falck; Mahesh P Paudyal; John E Moulder; John D Imig; Eric P Cohen
Journal:  Clin Sci (Lond)       Date:  2016-01-15       Impact factor: 6.124

10.  High-dose selenium for the mitigation of radiation injury: a pilot study in a rat model.

Authors:  Fritz Sieber; Sarah A Muir; Eric P Cohen; Paula E North; Brian L Fish; Amy A Irving; Marylou Mäder; John E Moulder
Journal:  Radiat Res       Date:  2009-03       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.